A description of the use of ALK-TKI treatment for patients with ALK positive advanced non-small cell lung cancer, co-authored by Quantify’s Rosa Lauppe and Mathias Lilja, has been published in the Acta […]
16
Nov 2022
16
Nov 2022
Quantify parterns with IFPA on Psoriasis study
Quantify Research CEO Kirk Geale and team are collaborating with Frida Dunger Johnsson and IFPA, the International Federation of Psoriatic Disease Associations, to assess […]
10
Nov 2022
Anders Gustavsson in Alzheimer panel
Quantify partner Anders Gustavsson participated in a panel on Alzheimer innovations and capacity challenges within the Swedish health care system. We call for 1) a National Alzheimer plan including a priority framework to identify and treat patients with […]
8
Nov 2022